The Biology Came First.

Over 20 partner-owned drug programs have reached clinical trials as a result of antibody discovery work performed by MindWalk scientists — ten currently in active Phase 1–3. The same scientific depth and biological intelligence infrastructure behind that record drives the Company’s work today. AUSTIN, Texas — MindWalk Holdings Corp. (NASDAQ: HYFT) today released a systematic... The post The Biology Came First. appeared first on Montreal Gazette .

Original source: Montreal Gazette